Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,625 | 5 | 73.2% |
| Consulting Fee | $2,375 | 2 | 20.2% |
| Food and Beverage | $785.26 | 30 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $11,380 | 15 | $0 (2022) |
| ABBVIE INC. | $95.04 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $92.93 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $37.44 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $27.28 | 2 | $0 (2024) |
| Dermavant Sciences, Inc. | $26.92 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $25.79 | 1 | $0 (2024) |
| Amgen Inc. | $24.74 | 1 | $0 (2023) |
| Biofrontera Inc. | $19.62 | 1 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $18.06 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.39 | 12 | ABBVIE INC. ($78.05) |
| 2023 | $63.17 | 3 | Amgen Inc. ($24.74) |
| 2022 | $93.87 | 5 | E.R. Squibb & Sons, L.L.C. ($48.54) |
| 2021 | $48.63 | 3 | AbbVie Inc. ($16.99) |
| 2019 | $2,756 | 3 | PFIZER INC. ($2,746) |
| 2018 | $3,955 | 5 | PFIZER INC. ($3,955) |
| 2017 | $4,652 | 6 | PFIZER INC. ($4,652) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DERMATOLOGY | ||||||
| 07/10/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ACNE | ||||||
| 06/04/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: DERMATOLOGY | ||||||
| 05/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Immunology | ||||||
| 04/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/22/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $5.31 | General |
| 03/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: Immunology | ||||||
| 03/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Immunology | ||||||
| 05/15/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Inflammation | ||||||
| 01/18/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.91 | General |
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.27 | General |
| Category: Immunology | ||||||
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.27 | General |
| Category: Immunology | ||||||
| 10/12/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO, DUOBRII | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Podiatry | ||||||
| 06/29/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: DERMATOLOGY | ||||||
| 04/14/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: DERMATOLOGY | ||||||
| 11/30/2021 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.53 | General |
| 09/15/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Immunology | ||||||
| 06/18/2019 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Immunology | ||||||
| 03/26/2019 | PFIZER INC. | EUCRISA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,981 | 3,379 | $559,407 | $130,324 |
| 2022 | 19 | 1,824 | 3,206 | $524,156 | $123,033 |
| 2021 | 17 | 1,912 | 3,394 | $529,639 | $134,005 |
| 2020 | 15 | 1,759 | 2,937 | $456,470 | $112,101 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 484 | 631 | $126,200 | $35,429 | 28.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 263 | 313 | $88,266 | $23,098 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 247 | $70,485 | $18,427 | 26.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 324 | 446 | $85,632 | $13,657 | 15.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 181 | 214 | $56,282 | $11,110 | 19.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 230 | 1,183 | $39,039 | $5,350 | 13.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 19 | $16,967 | $3,969 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $14,472 | $3,478 | 24.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $8,820 | $2,467 | 28.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 42 | 68 | $8,228 | $2,239 | 27.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 17 | $8,840 | $2,137 | 24.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 23 | 25 | $7,650 | $2,039 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 56 | $7,168 | $1,889 | 26.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $6,327 | $1,744 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,125 | $1,687 | 23.7% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 24 | 31 | $7,719 | $1,591 | 20.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 17 | $187.00 | $12.85 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 499 | 686 | $135,670 | $37,507 | 27.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 254 | 303 | $85,212 | $21,831 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 174 | $48,960 | $13,972 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 282 | 399 | $76,410 | $12,843 | 16.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 147 | 176 | $46,106 | $9,713 | 21.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 200 | 1,140 | $37,484 | $5,304 | 14.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 15 | 15 | $13,309 | $3,310 | 24.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $10,988 | $2,570 | 23.4% |
About Dr. Jill Nelson, M.D
Dr. Jill Nelson, M.D is a Dermatology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164531158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Nelson, M.D has received a total of $11,785 in payments from pharmaceutical and medical device companies, with $216.39 received in 2024. These payments were reported across 37 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,625).
As a Medicare-enrolled provider, Nelson has provided services to 7,476 Medicare beneficiaries, totaling 12,916 services with total Medicare billing of $499,463. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Pediatric Dermatology
- Location Omaha, NE
- Active Since 08/30/2006
- Last Updated 07/11/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1164531158
Products in Payments
- EUCRISA (Drug) $11,380
- Sotyktu (Drug) $92.93
- VRAYLAR (Drug) $44.49
- BOTOX (Biological) $33.56
- VTAMA (Drug) $26.92
- DUPIXENT (Biological) $25.79
- Enbrel (Biological) $24.74
- AMELUZ (Drug) $19.62
- JUBLIA (Drug) $18.06
- AKLIEF (Drug) $17.37
- SKYRIZI (Biological) $16.99
- TREMFYA (Drug) $16.46
- Cimzia (Drug) $15.11
- REMICADE (Biological) $10.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Omaha
Joel Schlessinger, M.d, M.D
Dermatology — Payments: $307,419
Rachel Person, Aprn, APRN
Dermatology — Payments: $89,556
Dr. Mathew Davey, M.d, M.D
Dermatology — Payments: $34,777
Nicole Harter, M.d, M.D
Dermatology — Payments: $12,870
Dr. Herschel Stoller, M.d, M.D
Dermatology — Payments: $12,186
Dr. Ronald Sulewski, M.d, M.D
Dermatology — Payments: $11,027